Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCA in Malignant Gliomas and GBM
NCT00540176Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Oct 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dichloroacetate in malignant glioma, glioblastoma multiforme (GBM), sponsored by University of Alberta. Started Oct 2007; status: completed.
02
Drugs
dichloroacetate
03
Conditions
malignant gliomaglioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00540176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540176.